Teladoc Health/$TDOC
1D1W1MYTD1Y5YMAX
Capital at risk
About Teladoc Health
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
- Ticker
- $TDOC
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 5,124
- Headquarters
- New York, United States
- Website
- www.teladochealth.com
Teladoc Health Metrics
BasicAdvanced
$1.1B
-
-$0.99
2.13
-
Price and volume
Market cap
$1.1B
Beta
2.13
52-week high
$9.89
52-week low
$4.40
Average daily volume
3.4M
Financial strength
Current ratio
0.831
Quick ratio
0.72
Long term debt to equity
0.023
Total debt to equity
0.783
Interest coverage (TTM)
-7.30%
Profitability
EBITDA (TTM)
53.137
Gross margin (TTM)
68.97%
Net profit margin (TTM)
-7.13%
Operating margin (TTM)
-5.85%
Effective tax rate (TTM)
2.85%
Revenue per employee (TTM)
$490,000
Management effectiveness
Return on assets (TTM)
-3.22%
Return on equity (TTM)
-12.99%
Valuation
Price to revenue (TTM)
0.441
Price to book
0.85
Price to tangible book (TTM)
-7.5
Price to free cash flow (TTM)
9.29
Free cash flow yield (TTM)
10.76%
Free cash flow per share (TTM)
0.661
Growth
Revenue change (TTM)
-2.08%
Earnings per share change (TTM)
-16.91%
3-year revenue growth (CAGR)
-0.55%
10-year revenue growth (CAGR)
38.48%
3-year earnings per share growth (CAGR)
-65.74%
10-year earnings per share growth (CAGR)
-4.26%
What the Analysts think about Teladoc Health
Analyst ratings (Buy, Hold, Sell) for Teladoc Health stock.
Analyst projections of the future price of Teladoc Health stock.
Bulls say / Bears say
Integrated Care is proving resilient: second-quarter revenue rose 1% and its adjusted EBITDA margin reached 16.5%. International revenue grew at a double-digit rate and chronic-care enrolment continued to rise, helping offset weaker subscription revenue. (GlobeNewswire, StockAnalysis)
Teladoc maintained its 2026 free-cash-flow guidance of $130 million to $170 million and slightly raised the midpoint of its adjusted EBITDA guidance. This suggests cost controls and the higher-margin Integrated Care mix can support cash generation even during the turnaround. (GlobeNewswire)
The shift to insurance could give BetterHelp a larger and more durable market: insurance revenue was near the high end of quarterly expectations, and management accelerated the nationwide rollout after strong consumer demand. If Teladoc expands provider capacity, this could replace declining cash-pay demand with better-covered sessions. (GlobeNewswire, Fierce Healthcare)
BetterHelp revenue fell 12% year on year in the second quarter, forcing Teladoc to cut its 2026 revenue guidance by about 5% at the midpoint. Management now expects BetterHelp revenue to decline 12.7% to 19.0% for the year. (GlobeNewswire)
Profitability remains fragile: second-quarter net loss widened to $38.9 million, adjusted EBITDA fell 5%, and BetterHelp's adjusted EBITDA margin was only 0.2%. The business is also having to invest in its insurance transition while cutting advertising as cash-pay demand weakens. (GlobeNewswire)
Teladoc had $774 million of cash against $1.0 billion of convertible notes due in 2027, while still reporting GAAP losses. That maturity creates refinancing or repayment risk if cash generation weakens or capital markets become less favourable. (Last10K)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.
Teladoc Health Financial Performance
Revenues and expenses
Teladoc Health Earnings Performance
Company profitability
Upcoming events
No upcoming events
Teladoc Health News
AllArticlesVideos
Teladoc appoints insurance executive Michael Grasher as CFO
Reuters4 weeks ago
Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
Business Wire2 months ago
Teladoc Stock Plummets on Revenue Miss, Lowered Outlook
Schaeffers Research2 months ago
Funds containing Teladoc Health
AllEURUSDGBP
Fund name | Fund size | $TDOC weighting |
|---|---|---|
iShares Ageing Population€AGED | €822M | 0.10% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.04% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.